The Beauty Health Company to Present at Spring 2022 Investor Conferences

The Beauty Health Company (NASDAQ: SKIN), the breakthrough category creator at the intersection of traditional beauty and aesthetics, today announced that President and Chief Executive Officer Andrew Stanleick and Chief Financial Officer Liyuan Woo will present at several investor conferences this spring:

Cowen & Company 6th Annual Future of the Consumer Conference

Tuesday, May 24, 2022, 3:50 p.m. ET

William Blair 42nd Annual Growth Stock Conference

Thursday, June 9, 2022, 1:00 p.m. ET

Jefferies Global Consumer Conference

Monday June 20 – Wednesday June 22, 2022

Replays of the presentations will be available on the company’s investor relations website at https://investors.beautyhealth.com/ following each event.

About The Beauty Health Company

The Beauty Health Company (NASDAQ: SKIN) is a global category-creating company focused on delivering beauty health experiences by reinventing our consumer’s relationship with their skin, their bodies and their self-confidence. Our flagship brand, HydraFacial, created the category of hydradermabrasion by using a patented Vortex-Fusion Delivery System to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. HydraFacial provides a non-invasive and approachable experience with a powerful community of aestheticians, consumers and partners, bridging medical aesthetics to beauty to democratize and personalize skin care solutions across ages, genders, skin tones, and skin types. HydraFacial is available in over 90 countries with an install base of 21,719 Delivery Systems providing millions of experiences to consumers each year. Find a local HydraFacial at https://hydrafacial.com/find-a-provider/. For more information, visit www.beautyhealth.com.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.